Abide Therapeutics is a biopharmaceutical company that identifies, develops, and validates small-molecule inhibitors that target serine hydrolases. Its lead program focuses on addressing neurological diseases with limited treatment options through the inhibition of the serine hydrolase monoacylglycerol lipase (MGLL).
|HQ||San Diego, US||Map|
Abide Therapeutics total Funding
Abide Therapeutics latest funding size
Time since last funding
|9 years ago|
When was Abide Therapeutics founded?
Abide Therapeutics was founded in 2011.
Who are Abide Therapeutics competitors?
Competitors of Abide Therapeutics include Akcea Therapeutics, Clearside Biomedical and Radius Health.
Where is Abide Therapeutics headquarters?
Abide Therapeutics headquarters is located at 10835 Rd to the Cure #250, San Diego.
Where are Abide Therapeutics offices?
Abide Therapeutics has offices in San Diego and Princeton.
How many offices does Abide Therapeutics have?
Abide Therapeutics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies